VMBIP E-newsletter, September 26, 2008
VMBIP Updates

•	Reminder:  If you want to cancel provider flu orders that are held at CDC, please contact Dale Verell dverell@cdc.gov or (404) 639-8770, not McKesson Specialty Customer Care.  Please see the following source documents for reference:  page 3 of the document entitled “Quick Reference Guide for PPOCs” that was attached to the September 19 VMBIP e-newsletter, and page 4 of the document entitled “Grantee Guidance for Flu Vaccine Ordering 2008-2009 Season” distributed as an all-grantee message on August 3. 
•	For grantees with IG products such as HBIG in their virtual inventory:  we strongly encourage you to utilize McKesson to ship IG products only as a replacement system, to the greatest extent possible.  For example, we encourage you to arrange for birthing hospitals in your jurisdiction to keep a supply of HBIG on hand and then utilize McKesson to replace doses used.  McKesson successfully rushes shipments of IG products to providers in response to urgent needs; however, the preferred practice would be a non-urgent vaccine replacement system. 
•	Havrix® (Hepatitis A) Pediatric vaccine, NDC 58160-0825-46, 10-pack single dose syringe is temporarily unavailable from GlaxoSmithKline.  The NDC has been turned off in VACMAN until further notice.  We expect the syringe presentation will be available for distribution at the McKesson Memphis and Sacramento distribution centers in mid-October.  An all-grantee message will be sent when the NDC has been turned on in VACMAN and product is available for distribution at McKesson.  Provider orders currently on backorder will be filled when product is received.  Please inform providers that the Hep A, NDC 58160-0825-11, 10-pack single dose vial is available for distribution at both McKesson sites.  If you have questions, please contact Joy Hill bme9@cdc.gov or (404) 639-8825.

VMBIP Performance Dashboard
Due to the hurricane activity the past few weeks in which grantees requested holds on orders, plus a recent IT problem in transmitting orders from CDC to McKesson, the scorecards are being postponed until next week so that further data analysis can be conducted to reflect performance accurately. 

As a reminder, VMBIP related all-grantee messages are posted to the VMBIP website at http//www.cdc.gov/vaccines/programs/vmbip/documents.htm and previous newsletters are posted at http//www.cdc.gov/vaccines/programs/vmbip/newsletters.htm 

If you have any questions or comments about the contents of this email, please contact Brad Prescott bap3@cdc.gov and Julie Orta jio7@cdc.gov, with a cc to your POB project officer. 

Brad Prescott
Project Lead
Vaccine Management Business Improvement Project 
Immunization Services Division 
Centers for Disease Control and Prevention
404-639-8796 (direct)
404-639-8627 (fax)
bap3@cdc.gov

This document can be found on the CDC website at:
http://www.cdc.gov/vaccines/programs/vmbip/downloads/newsletters/downloads/newsletters/vmbip-nl-09-26-08.rtf